Idexx Laboratories Extended warranties and post contract support — Deferred Revenue increased by 0.7% to $27.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $25.80M to $27.30M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong growth in service contract sales and a larger future revenue pipeline.
This represents the total amount of consideration received from customers for extended warranties and post-contract supp...
Standard metric for companies with subscription or service-heavy business models.
idxx_segment_extended_warranties_and_post_contract_support_deferred_revenue| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.40M | $26.00M | $26.00M | $25.70M | $25.80M | $25.20M | $25.80M | $26.30M | $26.30M | $27.10M | $27.30M |
| QoQ Change | — | -1.5% | +0.0% | -1.2% | +0.4% | -2.3% | +2.4% | +1.9% | +0.0% | +3.0% | +0.7% |
| YoY Change | — | -1.5% | — | — | — | -3.1% | -0.8% | +2.3% | +1.9% | +7.5% | +5.8% |